Canadian Respiratory Journal / 2017 / Article / Tab 4

Research Article

Readability and Suitability of COPD Consumer Information

Table 4

Readability of patient medication information.

InhalerFlesch Reading EaseGunning FogFlesch-Kincaid Grade LevelColeman-Liau IndexSMOG IndexAutomated Readability IndexLinsear Write Formula

Advair Diskus58.911.28.5118.38.48
Airomir44.814.212.5111212.515.4
Anoro Ellipta54.1119.6109.68.710.6
Apo-Salvent CFC Free48.814.112.21010.712.415
Atrovent HFA42.615.612.81211.813.415.1
Breo Ellipta55.911.810109.510.111.8
Bricanyl Turbuhaler44.313.511.81310.812.312.9
Combivent Respimat30.617.314.91413.515.617.3
Duaklir Genuair35.515.713.91312.914.516.2
Foradil Aerolizer46.41310.81210.210.511.1
Incruse Ellipta58.210.78.9108.68.48.7
Inspiolto Respimat33.115.413.91312.514.215.3
Novo-Salbutamol HFA45.213.712.1111112.213.8
Onbrez Breezhaler51.311.710.1138.8119.4
Salbutamol HFA5013.211.41110.511.613.7
Seebri Breezhaler49.112.511129.111.911.6
Serevent Diskhaler Disk58.710.78.5118.48.78
Serevent Diskus58.110.98.6118.58.48.1
Spiriva46.513.411.51210.911.813.1
Spiriva Respimat42.314.212.41211.612.514.1
Striverdi Respimat41.113.912.31311.712.913.6
Symbicort58.99.88.6108.68.18.3
Tudorza Genuair47.513.5111210.81112.3
Ultibro Breezhaler45.612.711.41310.112.112.1
Ventolin Diskus45.114.312.91111.213.715.7
Ventolin HFA51.413.211.31010.511.513.7

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.